Old knowledge. New science. Smarter medicine.
AI-engine for combinatorial drug discovery
Biovizions designs drug combinations — not single molecules — engineered with AI for safer, smarter medicine.
Our drug discovery engine
We design combinations, not single molecules
One engine profiles each molecule, designs the combination, and ranks it for the lab — every wet-lab screen feeds back to sharpen the next round.
Increase bioavailability
Pair compounds and carriers so more of the drug reaches its target — more on target, less drug needed.
Reduce dosage
Synergy lets each component work at a fraction of its solo dose — shrinking toxicity at the source.
Reduce toxicity & resistance
Lower, smarter dosing widens the safety window and slows the resistance that defeats single agents.
Old knowledge. New science. Smarter medicine.
OUR IMPACT
Combinatorial drug design enables what single molecules can't
Forcing a single drug to work means pushing the dose — and toxicity, resistance, and failure climb with it. Designed combinations change the equation on three fronts.
Restore potency, outpace resistance
High, constant dosing breeds resistance — projected to cause ~39M deaths a year by 2050. Designed combinations hit several targets at once, restoring potency and slowing escape.
Block every escape route
Tumors slip past single high-dose agents. Combinations close multiple resistance pathways at once — so cancers have nowhere left to run.
Widen the safety window
Toxicity rises with dose — adverse drug reactions kill ~100K Americans a year. Lower-dose synergy and better bioavailability widen the therapeutic window.
Sources: Lancet GRAM 2024 (AMR mortality) · FDA CDER (adverse drug reactions).
About us
We're a multidisciplinary team spanning computational modeling, the wet lab, and the clinic — the full arc of combinatorial drug discovery under one roof. AI and machine learning, hands-on assay development, and deep clinical experience come together so every combination we design is grounded in real biology, from the first prediction to the final validation.
Smarter combinations. Smaller doses. Better medicine.
Make every dose count
Making every dose count — designing intelligent drug-adjuvant combinations that deliver better outcomes with less medicine. By helping each drug work harder at a lower dose, we work to reduce side effects, outpace resistance, and keep treatments effective for longer.
The medicine of the future
A future where millennia of wisdom from eastern traditional medicine help shape how we design tomorrow's therapies. These systems have long understood that the right combination can do what no single ingredient can — and we bring AI and modern science to turn that principle into precise, validated, clinically-ready medicine.
About the team
Founders & advisory board
Two founders building it — guided by advisors across AI and clinical translation.
Founders
Dr. Nachiket Shankar
Dr. Prateek Shetty
CTO
Scientific Advisory Board
Contact
Let's build smarter medicine.
For research collaboration and partnership inquiries, we'd love to hear from you.
nachishankar@biovizions.com